Align Technology (NASDAQ:ALGN) Surpasses Q4 CY2025 Sales, Shares Soar

[Para 1: The Lead] Align Technology (NASDAQ:ALGN) exceeded Wall Street's revenue expectations in Q4 CY2025, reporting sales of $1.05 billion, a 5.3% year-over-year increase. The company's non-GAAP profit of $3.29 per share surpassed analysts' consensus by 10.8%. Shares of ALGN surged upon the release of these results. [Para 2-3: Supporting details & Context] Align Technology, a leader in dental technology, designs and manufactures Invisalign clear aligners and iTero intraoral scanners. The company's sales growth, driven by its clear aligner shipments, which increased 4.6% year-over-year, indicates strong customer demand. Analysts project a 3.4% year-over-year revenue growth for the next 12 months, slightly below its historical trend but still reflecting solid performance. ALGN's adjusted operating margin of 26.1% in Q4 CY2025, up 3 percentage points from the previous year, highlights operational efficiency. The stock's immediate reaction, climbing 7% to $172.64, reflects investors' positive response to the earnings report.